1 completed, 1 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow ST-segment Elevation Myocardial Infarction (STEMI): new trials by email Literature Review of ST-segment Elevation Myocardial Infarction (STEMI) trials Research Report on ST-segment Elevation Myocardial Infarction (STEMI)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical Trial Fexofenadine Hydrochloride, Placebo - ST-segment Elevation Myocardial Infarction (STEMI) | Phase 2 | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 160 | 2025-01-20 | 2026-09-16 |
| Pharmacoinvasive Therapy With Prourokinase Prourokinase, Placebo - ST-segment Elevation Myocardial Infarction (STEMI) | Phase 2 / Phase 3 | Completed | Suzhou Landing Pharmaceuticals | 197 | 2008-11-01 | 2012-07-27 |
ST Elevation Myocardial Infarction (2)
Cardiovascular Diseases (2) · Heart Diseases (2) · Infarction (2) · Ischemia (2) · Myocardial Infarction (2) · Myocardial Ischemia (2) · Necrosis (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Vascular Diseases (2)
fexofenadine (1) · saruplase (1)
Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Suzhou Landing Pharmaceuticals (1)
China (2)
Xinyang Hu, PhD (1)